Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Pinnacle Seed Inc. manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is 1 pending office action currently active for this portfolio. This action is assigned to 1 distinct examiner and 1 distinct art unit, representing a concentrated prosecution effort. For a practitioner, this means that the company's current legal activity at the patent office is highly focused, with all communication and negotiation occurring within a single art unit and with one examiner.
RADOSAVLJEVIC, ALEKSANDAR is the busiest examiner for the company. This individual is responsible for 1 busiest examiner pending office action. Because the total number of pending office actions is 1, RADOSAVLJEVIC, ALEKSANDAR is the sole examiner currently working on the company's patent applications in the Biotechnology & Pharmaceuticals sector. This concentration suggests that the company's current patent goals are tied to a specific technical filing, making the outcome of this single pending office action a primary focus for its intellectual property management.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RADOSAVLJEVIC, ALEKSANDAR | 1 | 80.8% | +6.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19173408 | SWISS CHARD VARIETY 'RHDF-611 23' | RADOSAVLJEVIC, ALEKSANDAR | — |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19173408 | SWISS CHARD VARIETY 'RHDF-611 23' | RADOSAVLJEVIC, ALEKSANDAR | 1662 | §112 | Non-Final OA | — | Pending | Apr 08, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPinnacle Seed Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Aleksandar Radosavljevic has the most, with 1 of Pinnacle Seed Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
